- Report
- January 2026
- 196 Pages
Global
From €3153EUR$3,545USD£2,722GBP
€3503EUR$3,939USD£3,025GBP
- Report
- August 2025
- 184 Pages
Global
From €3153EUR$3,545USD£2,722GBP
€3503EUR$3,939USD£3,025GBP
- Report
- January 2026
- 250 Pages
Global
From €3993EUR$4,490USD£3,448GBP
- Report
- May 2026
- 285 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 236 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 281 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 150 Pages
Global
From €4313EUR$4,850USD£3,724GBP
- Report
- October 2025
- 160 Pages
Global
From €2986EUR$3,358USD£2,578GBP
€3513EUR$3,950USD£3,033GBP
- Report
- March 2025
- 270 Pages
Global
From €4268EUR$4,799USD£3,685GBP
- Report
- June 2022
- 200 Pages
Global
From €4268EUR$4,799USD£3,685GBP
Hot Melt Extrusion (HME) is a process used in drug discovery to produce drug-loaded polymeric materials. It is a continuous process that involves melting and mixing of polymers and active pharmaceutical ingredients (APIs) at high temperatures. The resulting material is then extruded through a die to form a solid product. HME is used to produce drug-loaded polymeric materials with improved bioavailability, solubility, and stability. It is also used to produce drug-loaded polymeric materials with controlled release profiles.
HME is a cost-effective and efficient method for producing drug-loaded polymeric materials. It is also a versatile process that can be used to produce a wide range of drug-loaded polymeric materials.
Some companies in the Hot Melt Extrusion market include Elmarco, Thermo Fisher Scientific, and GEA Group. Show Less Read more